Price to Sales ratio Analysis of Ligand Pharmaceuticals Incorp. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY PS
Period Ending - Dec-23
Very Poor PS
9.83
Period Ending - Dec-22
Very Poor PS
7.31
Growth
34.50 %
Trailing Twelve Months PS
Period Ending - Dec-23
Very Poor PS
12.74
PS Analysis of Ligand Pharmaceuticals Incorp.
| P/S Ratio of Ligand Pharmaceuticals Incorp. with value of 12.74 indicates that stock price is high compared to sales of the company and may be overvalued. |
| PS Ratio of LGND rose handsomely by 34.50 % this year. |
| PS Ratio with value of 22.39 was highest in Year Dec-19 in last Five Years. |
| PS Ratio with value of 7.31 was lowest in Year Dec-22 in last Five Years. |
| Latest PS Ratio with value of 9.83 is lower than Average PS of 11.96 in last five years. |
Other PS Related Info of LGND that may interest you.
Ligand Pharmaceuticals Incorp. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| LGND | 85.05 | 83.96 | 1.30 % | Biotechnology |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..
PS Related Ratios
| PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Price to Sales of Ligand Pharmaceuticals Incorp.
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| PS | 9.83 | 7.31 | 8.43 | 11.84 | 22.39 | 13.05 | 22.69 |
| Change | 34.50 % | -13.31 % | -28.76 % | -47.14 % | 71.61 % | -42.48 % | -12.95 % |
FY Chart of Price to Sales of Ligand Pharmaceuticals Incorp.
Note : All Data Generated at the End of Trading Hours (EOD Data)